Biodesix

$3.81 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Biodesix

Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis in the United States.

Stock Analysis

last close $4.24
1-mo return -3.9%
3-mo return -45.1%
avg daily vol. 356.67T
52-week high 29.33
52-week low 4.02
market cap. $128M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $74M
inst own. 15.8%
baraka

Subscribe now for daily local and international financial news

Subscribe